Journal of medicinal and pharmaceutical chemistry 2015-07-01

Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.

E M Balboa, Y-X Li, B-N Ahn, S-H Eom, H Domínguez, C Jiménez, J Rodríguez

文献索引：J. Med. Chem. 52 , 858-67, (2009)

全文：HTML全文

摘要

The bioisosteric replacement of the phenol ring, a signature functional group of most estrogen receptor (ER) ligands, with a hydrogen-bonded pseudocyclic ring, led to the development of a novel class of nonsteroidal ER-ligands based on a salicylaldoxime template. A series of structural modifications were applied to selected molecules belonging to the monoaryl-salicylaldoxime chemical class in an attempt to improve further their ERbeta-selective receptor affinity and agonist properties. Among several modifications, the best results were obtained by the simultaneous introduction of a meta-fluorine atom into the para-hydroxyphenyl substituent present in the 4-position of salicylaldoxime, together with the insertion of a chloro group in the 3-position of the central scaffold. The resulting compound showed the best affinity (K(i) = 7.1 nM) and selectivity for ERbeta over ERalpha. Moreover, in transcription assays, it proved to be a selective and potent ERbeta-full agonist with an EC(50) of 4.8 nM.